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chondrocytes, osteoblasts and odontoblasts, and then
followed by the propagation of the hydroxyapatite into
the extracellular matrix and between collagen fibrils)1.
Inorganic pyrophosphate (PPi) inhibits hydroxyapatite
formation. Tissue-nonspecific alkaline phosphatase
(TNSALP) hydrolyses PPi into phosphate (Pi), and this
ba lance is fundamental to the mineralization1-3. There
are 4 isomeres of the alkaline phosphatase (AP):
TNSALP, intestinal, placenta and germ cell. All of them
are homodimeric ectoproteins anchored to the plasma
membrane by a phosphatidylinositol glycan (PIG) moie -
ty. TNSALP clives PPi, pyridoxal-5-phosphate (PLP- an
activated form of vitamin B6) and phosphoetha -
nolamine (PEA) in its dimeric form at physiologic pH,
and whose expression changes according to the age2.
Hyphosphatasia (HP) is a rare genetic disease caused
by a low activity of the TNSALP with defective bone
and teeth mineralization4. Clinical expression varies
with the type of mutation and the age of diagnosis1-4.
The incidence of the severe forms is estimated in
1/100000 (USA), but because its incomplete pene-
trance it is difficult to know the correct prevalence.
ALPL, the gene encoding TNSALP, presents more than
190 mutations, some of them target specific popula-
tions or regions2,4, and with a good genotype-pheno-
type correlation2,5,6. There are 6 clinical forms: perina-
tal (lethal or benign), infantile, childhood, adult and
odontohypophosphatasia (Table I)1-4.
The childhood form is characterised by low bone
mineral density and unexplained fractures, premature
loss of deciduous teeth (beginning with incisors), short
stature and delay in walking, bone pain (bone oede-
ma), joint pain (condrocalcinosis and osteoarthritis de-
velop with aging), pseu dofracture in the lateral cortex
of the femoral diaphysis (Looser zones), and sometimes
a waddling gait2-4. Specific diagnostic clues are shown
in Table I, but screening for mutations in ALPL is es-
sential to confirm the diagnosis4. Childhood form does
the differential diagnosis with rickets, osteogenesis
imper fecta, dentinogenesis imperfecta, cleidocranial
Childhood hypophosphatasia with myopathy: 
clinical report with recent update
ACTA REUMATOL PORT. 2012;37:92-96
AbstrAct
Hypophosphatasia is a rare genetic disease with low tis-
sue nonspeficic alkaline phosphatase activity
(TNSALP), due to ALPL gene mutation. There are 6
clinical forms. Childhood form is caractheri zed by short
stature, premature loss of decidous teeth and diffuse
bone pain associated with a pathological bone fracture
in the past. Laboratory findings present low serum le -
vel of alkaline phosphatase and high levels of serum
and urinary extracelular metabolytes. It is described a
case report of a 34 years old woman with previous diag -
nosis of childhood hypophosphatasia, caryotype
46,XX, and molecular screening for the gene ALPL with
a c.1426>A p.E476K mutation, who complained of
proximal muscular weakness intensified with the cold
weather,  exercise, and a waddling gait. The elec-
tromyography was compatible with myopathy but the
muscle biopsy was normal. The serum crea tine kinase
levels were normal, as well  as the others muscle en-
zymes. Clinical and laboratory/ /imaging dissociation is
frequent in other metabo lic bone diseases as osteoma-
lacia. The rarity of this case of childhood hypophos-
phatasia with “de novo” non-progressive myopathy of
the lower limbs, justified a case report with literature re-
vision. 
Keywords: Hypophosphatasia; Myopathy; Alkaline
Phosphatase; Osteomalacia. 
IntroductIon
Biomineralization is a process by which hydroxyapatite
is deposited in the extracellular matrix (first within ma-
trix vesicles that bud from the surface membrane of
Silva I1, Castelão W1, Mateus M1, Branco JC2,1
ÓRgÃO OFICIAL dA SOCIEdAdE PORTUgUESA dE REUMATOLOgIA
93
Silva i e col.
tAble I. clInIcAl feAtures of hypophosphAtAsIA
Type Inheritance Clinical features Dental features Diagnosis




Perinatal AR or AD Bowing of the long bones, 
–
Ultrasonographyd, clinical 
(benign) benign evolution evaluation
Infantil AR Craniosynostosis, Premature Radiographs, laboratory findings 
hypomineralization,  loss of the and clinical evaluation
rachitic ribs, hypercalciuria deciduous teeth
Childhood AR (frequent) Short stature, bone Premature loss 1. Radiographs: Bowdler spurs, 
or AD (rare) fractures/deformity, bone of the deciduous shortening of the long bones, low 
pain, waddling gait teeth (incisors) bone mineral density
2. Laboratory: low activiy of AP, serum
and urinary elevation of PEA, PLP,
PPi, normal phosphocalcium
metabolism, normal parathormone
and vitamin D levels
3. Bone biopsy: low mineralization 
of the cartilage, normal cells
4. Bone MRI: hyperemia and 
metaphyseal edema
Adult AR or AD Stress fractures: metatarsal, 
–
Radiographs, laboratory findings 
tibia; chondrocalcinosis and clinical evaluation
Odontohypo- AR or AD Alveolar bone loss Dental caries Laboratory, clinical and dental 
phosphatasia evaluation
Legend: AR= autosomal recessive; AD= autosomal dominant; AP= alkaline phosphatase; PEA = phophoethanolamine; 
PLP = pyridoxal-5-phosphate; PPi = inorganic pyrophosphate; MRI = magnetic resonance imaging.
dysostosis, Cole-Carpenter syndrome, idiopatic juve-
nil osteoporosis and renal osteodystrophy2. Milder
forms of hypophosphatasia pose a pro blem for an ac-
curate diagnosis7. Symptomatic treatment is applied,
with orthopedic management1-5,8. Positive response to
teriparatide as been reported and enzyme replacement
therapy (ERT) looks promi sing7.
It is presented a case report of hypophosphatasia
with myopathy and a literature revision.
cAse report
A 34-year-old woman was referred to our clinic with di-
fuse bone pain and myalgias of the lower limbs and of
the pelvic girdle that lasted for 10 years. Two years be-
fore she started with mild proxi mal muscle weakness
in her lower limbs and pelvic girdle, with difficulty in
walking and inability to climb stairs. She also com-
plained of morning muscle stiffness for more than an
hour. Her complaints intensified with physical de-
manding activities and with cold weather. She pre-
sented previous history of early delivery at 30 weeks,
growth retardation, dental caries, pathologic coccyx
fracture and the diagnosis of childhood hypophos-
phatasia (caryo type 46,XX; autosomal recessive; mu-
tation c.1426G>A p.E476K heterozygote – Institut für
Humangenetik, Universitatsklinikum Schleswig-
-Hols tein, Kiel, Germany) when she was 20 years old. 
The physical examination revealed short stature
(weight 48 Kg; height 140 cm) (Figure 1), shorte ning
of the 4th metatarsals, mild (grade 4/5) proximal mus-
cle weakness in the lower limbs with difficulty in get-
ting off the floor and in climbing stairs and a waddling
gait. Deep tendon reflexes were normal and the mus-
cles were not tender.
Serum AP showed low levels (28 U/L) without 
other abnormality in the muscle enzymes. Serum, uri-
nary and immunologic analysis were normal (PPi, PLP
and PEA were not performed). Radiologi cal examina-
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tion showed widening of the bone structures in the
knee joint, shortening of the 4th metatarsals (Figure 2)
and acetabular dysplasia (Figure 3). Electromyogra-
phy of the lower limbs showed spontaneous fibrilla-
tions, polyphasic and low amplitude motor action po-
tentials. Muscle biopsy specimens of the left quadri-
ceps were exa mined by light microscopy and histo-
chemistry, showing freezing artefacts, periferic
nucleus, type I muscular fibres predominance, with
normal dia meter. The image was not available by the
patholo gist and the patient refused another biopsy for
the muscular enzymatic study and the electron mi-
croscopy analysis. Mucopolysaccharidoses were ex-
cluded by lysosomic studies. Bone densitometry study
showed cortical osteoporosis (T-score: -2,5) and lum-
bar vertebral magnetic resonance imaging was normal.
The patient was diagnosed with myopathy associa -
ted with metabolic bone diseases. She star ted on
sympto matic treatment with vigilance of stress frac-
tures, pseudofractures and dental care. The cortical os-
teoporosis was treated with teriparatide.
dIscussIon
We describe a case report of a woman with the previ-
ous diagnosis of childhood hypophosphatasia who
complains of myalgias and severe diffuse bone pain of
the lower limbs for 10 years . Symptons of “de novo”
myopathy of the lower limbs and pelvic girdle began
2 years ago. The radiologic and biochemical findings
were characteristic of hypo phosphatasia. The elec-
tromyography of the lower limbs showed myopathy,
but the biopsy did not showed pathognomonic alte -
rations. The bone densitometry study showed cortical
osteoporosis. We explored the myopathy etiology in
this patient. Adults with myopathy usually present
proximal and symmetric muscle weakness, myalgias
at rest, exercise intolerance, serum elevation of creatine
kinase (CK) or myoglobinuria.  The patient had typi-
cal symptons of myopathy: weakness, myalgia and
stiffness. Her symptons worsened with demanding
metabolic exercises but sometimes persisted even in
rest periods. 
First it was excluded non-neuromuscular episodic
or persistent causes of weakness (hypotension, hy-
poxia, hyperventilation, hypoglycemia, anemia, infec-
tion, malignancy, malnutrition, hyperthyroidism, hy-
perparathyroidism, hypophosphatemia)9. 
fi gu re 1. Short stature (weight 48 Kg and height 140 cm)
fi gu re 2. Feet radiograph with short 4th metatarsals
fi gu re 3. Hip radiography with acetabular dysplasia
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Investigation for causes of proximal muscle weak-
ness (inflammatory, drug and toxin-induced, infec-
tions, metabolic, muscular dystrophies, muscle chan-
nelopathies, neoplasm) were negative9. 
Polymyositis, dermatomyositis, inclusion body
myositis and connective tissue diseases were exclu ded
by the clinical, biochemical and hystological findings.
She had no sarcoidosis or Behçet clini cal features. She
had no history of drugs with the potential of inducing
the symptons and no history of previous infection. 
Although the enzymatic muscle study was not been
performed, her symptons were not compati ble with
glycogen storage diseases (e.g. rabdomyo lisis with
exer cise, relieve at rest, normal electromyography,
posi tive PAS byopsy and low serum lactate after exer-
cise), with lipid storage diseases (e.g. rabdomyolisis,
byopsy stained by Sudan red and high levels of serum
lactate after exercise and in fasting) or mitochondrial
myo pathies (e.g. abnormalities of the oxydative meta -
bo lism, myoglobinuria, systemic symptons, palpebral
ptosis, seizures, retinopathy, ophthalmoplegia, cardyo -
myopathy)9,10. Endocrine, nutritional and electrolyte
disorders were excluded. Neuropatic conditions typi-
cally manifest with asymmetric weakness, distal in-
volvement, sensorial alterations or abnormalities in the
cranial nerves function. Muscular dystrophies were
less likely by the biopsy, electromyography and the
normal neurologic exa mination in facial, palpebral and
upper limbs muscular strengh9. 
Finally it was selected the only characteristic that
could associate the patient complains with specific
diag nosis: myopathy associated with rest pain. In this
case we considered childhood dermatomyositis, hypo -
thyroid myopathy,  drug-induced myopathy, infectious
myopathy, myo pathies associated with metabolic bone
diseases and carnitine palmitoyl transferase deficien-
cy. From the previous discussion the most likely cause
is myopathy associated with metabolic bone di seases.
The most similar metabolic bone disease with re-
ported myopathy is osteomalacia. Although the bio-
chemical and biopsy findings are different between hy-
pophosphatasia and osteomalacia, clini cal symptons,
radiologic findings and myopathy caractheristics are
similar (Table II). Muscle fibres depend on 4 metabo -
lic processes to replenish adenosine triphosphate
stores during exercise: the CK reaction, glycogenoly-
sis, oxidative phosphorilation and adenylate kinase
and myoadenylate deaminase reactions9. Considering
the osteomalacea myopathy9,11,12 and concerning that
this patient with hypophosphatasia has the same com-
plains it was formulated 2 hypothesis for its etiolo gy:
low intramuscular levels of phosphate would difficult
glycolysis during demanding metabolic situations
and/or a possible low intracellular calcium intake by
the sarcoplasmatic reticulum proba bly by low activity
of vitamin D in the myo cytes. Even with normal levels
of serum vitamin D it must be assured that its actions
in the myocytes is complete or is deficient.
Hypophosphatasia treatment is symptomatic. Anti-
-inflammatory non steroid  drugs (AINEs) appear
bene ficial in bone pain, blocking pros ta glandins (PGs)
synthesis for a long period of time and suppressing the
bone oedema8. Girschick et al, supports that PGs ele-
vation in HP might be explained by the impaired clea -
Legend: AP = alkaline phosphatase; PTH = parathormone
tAble III. clInIcAl feAtures of hypophosphAtAsIA And osteomAlAcIA
Osteomalacia Hypophosphatasia
Serum AP high levels Serum low AP levels
Low vitamin D serum level and PTH elevation Normal serum levels of vitamin D and PTH
Hypercalcemia, hypophosphatemia Normal serum levels of calcium and phosphate
Biopsy: descontinuous atrophic changes in the muscle Biopsy: no atrophic signs, peripherical nucleus, 





Diffuse bone pain worse with the cold and the exercise
Proximal muscular weakness of the pelvic girdle and the lower limbs
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rance of calcium pyrophosphate resulting from alka-
line phosphatase deficiency. PGs can reduce physical
activity in these patients, thus AINEs may improve
exer cise tolerance and bone mineralization8. The cor-
tical osteoporosis was treated with teriparatide (during
18 months) with improvement of the pain complains,
together with calcium 1g/d and vitamin D 800 UI/d
(increases the number of type II fibres with gait stabi-
lization and prevention against falls).
Vigilance of serum and urinary calcium levels must
be done once parathormone and vitamin D levels are
normal. In these patients the bisphosphonates are
avoidable as they have a similar conformation to PPi
and inhibit bone mineralization. Teriparatide seems to
upregulate wildtype ALPL gene expression, to reduce
bone pain, to increase AP serum activity and to im-
prove biochemical markers of bone turnover. Published
data support our decision13,14. 
Glucosamine sulfate 1500mg/d may prevent secon -
da ry osteoarthritis13. Low impact exercises are impor -
tant to improve muscle mass and maintain the mecha -
nical stimuli that avoids the acute loss of bone in the
muscle paralysis. Gross TS15, published that acute res -
ponse to transient muscle paralysis is due to a RANKL
mediated osteoclastic activation and that it is restric -
ted to the affected limb. Vigilance of stress fractures,
pseudofractures and dental care are mandatory2.
ERT has been developed and tested in mouse and
clinical trials soon will be available to patients2. Millan
and colleagues showed that ERT with a semi-synthe -
tic bone-targeted form of TNSALP can prevent bone
abnormalities of HP in the mouse7. Allogeneic trans-
plant of human mesenchymal stem cells in the child
(allogeneic cultured osteoblasts and bone fragments
from crushed iliac bone; allogeneic HLA-matched 
T-cell-depleted marrow; allogeneic heterogeneous
popu lation of marrow cells and bone fragments) by
intrave nous administration resulted in clinical and
radiolo gic evidence of bone mineralization, some pa-
tients began to walk or run, and one child turn its phe-
notype to mild HP3.
In childhood HP the physician must perform a regu -
lar vigilance of the bone fractures, dental caries, serum
and urinary calcium levels, vitamin D serum levels and
general clinical examination. Foot orthotics may help
in the management of the tarsal fractures in adults2. This
form of HP presents a better prognosis than HP perina-
tal and infantil1-5.
This patient improved her symptons and keeps a
regu lar follow-up in the rheumatology department.
This report shows that a non-progressive proxi mal
myopathy with muscle pain and stiffness may be an
early sign of an osteomalacic syndrome.
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